Canadian biotech Medicago building $200M vaccine plant

Medicago's Research Triangle Park, NC, facility--Courtesy of Medicago

Medicago is building a $200 million manufacturing facility in Quebec City, where it will use plant technology to produce vaccines against Ebola and other viruses. The company is working with tobacco plants to make large quantities of vaccines. It has made flu vaccines for H1N1 and H7N9 in less than three weeks--much more quickly than making them using the traditional egg-based method. Medicago opened a facility in Research Triangle Park, NC, which can manufacture 10 million vaccine doses per month. More from FiercePharmaManufacturing